Key points are not available for this paper at this time.
The frequency of primary resistance to NNRTIs is increasing, although resistance to all available classes of antiretroviral therapy remains rare. Genotypic resistance testing in recently infected persons predicts time to viral suppression during therapy.
Robert M. Grant (Wed,) studied this question.